Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)

NCT04580134 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT04580134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04580134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
March 1, 2022
Completion date
April 30, 2027
Enrollment
524 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar 1 disorder, schizoaffective disorder, schizophrenia